Drapkin Kimberlee C Insider Trading Activity (LENZ)

Summary

Updated Jul 16, 2026

Drapkin Kimberlee C has filed 3 SEC Form 4 filings across 3 companies in the last 90 days.

Role	Director
Notability	30/100

Recent Transactions

Date	Ticker	Company	Code	Shares	Price	Value
2026-06-05	ABOS	Acumen Pharmaceuticals, Inc.	A — Grant or award	35.5K	$0.00
2025-06-30	KANT	KINETA, INC./DE	D — Derivative transaction	13.8K	—

Companies — Last 90 Days

LENZ Therapeutics, Inc. (LENZ) — 1 filings, last 2026-06-16
Climb Bio, Inc. (CLYM) — 1 filings, last 2026-06-08
Acumen Pharmaceuticals, Inc. (ABOS) — 1 filings, last 2026-06-05

Frequently Asked Questions

Who is Drapkin Kimberlee C?

Drapkin Kimberlee C is a corporate insider — currently tracked as Director of LENZ Therapeutics, Inc. (LENZ). InsiderAlpha tracks every SEC Form 4 filing in real time.

How many SEC Form 4 filings has Drapkin Kimberlee C submitted recently?

3 primary Form 4 filings in the last 90 days, covering 3 companies.

Where can I see all of Drapkin Kimberlee C's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Drapkin Kimberlee C — SEC Form 4 Insider Trading Activity